Clinical Trials in the EU / 2025-523297-16-00
Authorised, recruiting
Phase I
Phase 1 First-in-Human Study of JNJ-95566692 in Participants with NHLs
2025-523297-16-00 · tracked via the Priya Life Science EU tracker
Condition studied
Non-Hodgkin Lymphoid Malignancies (NHLs)
Eligibility
Official registry record
This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View 2025-523297-16-00 on CTIS ↗ ← All trials in the EU